window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : November 16, 2025

  • News
  • About Us
Contact Us

Series A funding

  • European biotech,Partnerships & Funding,Pharmaceuticals and therapeutics,Research & Development

    Enhanced Genomics extends Series A to $19m to advance autoimmune therapeutics pipeline

    Enhanced Genomics has secured an additional funding round, bringing its [...]

    September 22, 2025
  • Artificial Intelligence,Clinical Development,Global health,Medical devices,Partnerships & Funding

    Magentiq Eye secures Series A funding to advance AI-powered colonoscopy solutions

    Investment led by aMoon will support US and EU commercialisation [...]

    August 1, 2025
  • Artificial Intelligence,Clinical Development,Oncology,Partnerships & Funding,Precision medicine

    One Biosciences raises €15M to advance AI-driven single-cell oncology platform

    One Biosciences, a precision oncology techbio company specialising in clinical-grade [...]

    July 17, 2025
  • Artificial Intelligence,Cell & Gene Therapy,Clinical Trials,Drug Development

    Vivodyne raises $40M to advance human tissue testing as alternative to animal models

    Vivodyne has secured $40 million in Series A funding to [...]

    May 29, 2025
  • Patient Centricity,Technology and platforms,Uncategorised

    SpotitEarly targets US market with AI-canine breath test for early cancer detection

    A biotech company combining artificial intelligence with canine scent detection [...]

    May 22, 2025
  • Artificial Intelligence,Clinical Trials

    PhaseV raises $50M to expand AI-powered clinical trial platform

    PhaseV has secured $50 million in Series A funding to [...]

    May 13, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2025 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Clairity raises $43 million to launch FDA-authorized AI platform for breast cancer risk prediction
    Categories: Artificial Intelligence, Biotech, Clinical Development, Diagnostics, Digital Health, Drug Development, Global health, Healthcare leadership, Precision medicine, Women's Health
  • FDA approves Kura and Kyowa Kirin’s ziftomenib for relapsed or refractory AML
    Categories: Drug approval, Oncology, Pharmaceuticals and therapeutics
  • Successful treatment for ALS could deliver billions in global value
    Categories: Neurosciences, Rare Diseases, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top